Evidence map›Paper›PMID 32963065›Full record

ArticleBMJ open2020

Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol.

Harsukh Benipal, Anne Holbrook, J Michael Paterson, James Douketis, Gary Foster, Lehana Thabane

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02777047 (Coordination of Oral Anticoagulant Care at Hospital Discharge), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02777047 nacompletednot on this map

Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): A Pilot Randomized Trial

TypeinterventionalSponsorSt. Joseph's Healthcare HamiltonRan2020 to 2022Enrolled56ConditionsAnticoagulantsArmsAnticoagulation Coordinated Care
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Anticoagulant use and associated outcomes in older patients receiving home palliative care: a retrospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Harsukh BenipalDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Anne HolbrookDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada holbrook@mcmaster.ca.ORCID 0000-0002-3371-4187
J Michael PatersonICES, Toronto, Ontario, Canada.
James DouketisDepartment of Medicine, Division of Hematology and Thromboembolism, McMaster University, Hamilton, Ontario, Canada.
Gary FosterDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Lehana ThabaneDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Funding

Canadian Institutes for Health Research 365 834
6 · The paper itself

Abstract

introductionOral anticoagulants (OACs) are widely prescribed in older adults. High OAC-related adverse event rates in the early period following hospital discharge argue for an analysis to identify predictors. Our objective is to identify and validate clinical and continuity of care variables among seniors discharged from hospital on an OAC, which are independently associated with OAC-related adverse events within 30 days. METHODS AND ANALYSIS: We propose a population-based retrospective cohort study of all adults aged 66 years or older who were discharged from hospital on an OAC from September 2010 to March 2015 in Ontario, Canada. The primary outcome is a composite of the first hospitalisation or emergency department visit for a haemorrhage or thromboembolic event or mortality within 30 days of hospital discharge. A Cox proportional hazards model will be used to determine the association between the composite outcome and a set of prespecified covariates. A split sample method will be adopted to validate the variables associated with OAC-related adverse events. ETHICS AND DISSEMINATION: The use of data in this project was authorised under section 45 of Ontario's Personal Health Information Protection Act, which does not require review by a research ethics board. Results will be disseminated via peer-reviewed publications and presentations at conferences and will determine intervention targets to improve OAC management in upcoming randomised trials. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Identifier: NCT02777047; Pre-results.

Indexed as

AnticoagulantsHospitalsAgedCohort StudiesHumansOntarioRetrospective StudiesAnticoagulantsanticoagulationclinical pharmacologyepidemiologyprotocols & guidelinesstatistics & research methods

Identifiers

PMID32963065
PMCPMC7509956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.